Total Return Level Chart

View Total Return Level for JNJ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Return Level Chart
Start Trial

Historical Total Return Level Data

View and export this data back to 1990. Start Trial.
Date Value
September 11, 2026 633.73
September 10, 2026 635.57
September 09, 2026 637.31
September 08, 2026 642.18
September 04, 2026 656.76
September 03, 2026 664.39
September 02, 2026 656.71
September 01, 2026 647.12
August 31, 2026 634.37
August 28, 2026 639.60
August 27, 2026 634.18
August 26, 2026 644.28
August 25, 2026 651.77
August 24, 2026 648.35
August 21, 2026 641.70
August 20, 2026 634.89
August 19, 2026 649.23
August 18, 2026 643.77
August 17, 2026 623.01
August 14, 2026 618.22
August 13, 2026 622.32
August 12, 2026 619.43
August 11, 2026 616.91
August 10, 2026 621.68
August 07, 2026 615.58
Date Value
August 06, 2026 610.21
August 05, 2026 611.66
August 04, 2026 605.35
August 03, 2026 604.11
July 31, 2026 608.72
July 30, 2026 607.46
July 29, 2026 630.52
July 28, 2026 633.37
July 27, 2026 631.51
July 24, 2026 625.46
July 23, 2026 615.65
July 22, 2026 607.01
July 21, 2026 595.09
July 20, 2026 590.84
July 17, 2026 600.86
July 16, 2026 593.57
July 15, 2026 586.56
July 14, 2026 602.78
July 13, 2026 612.09
July 10, 2026 610.21
July 09, 2026 615.25
July 08, 2026 625.46
July 07, 2026 634.58
July 06, 2026 615.79
July 02, 2026 624.60

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Eli Lilly & Co. 2947.91
Merck & Co., Inc. 442.47
Pfizer Inc. 92.72
Bristol Myers Squibb Co. 240.78
Liquidia Corp. 66.74